Report Detail
Global (United States, European Union and China) Immuno-oncology Drugs Market Research Report 2019-2025
- RnM3690026 |
- 22 August, 2019 |
- Global |
- 120 Pages |
- QYResearch |
- Pharma & Healthcare
In 2019, the market size of Immuno-oncology Drugs is 49200 million US$ and it will reach 142200 million US$ in 2025, growing at a CAGR of 14.2% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Immuno-oncology Drugs.
This report studies the global market size of Immuno-oncology Drugs, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Immuno-oncology Drugs sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Amgen, Inc
AstraZeneca, Plc
Bristol-Myers Squibb
Celgene Corporation
Eli Lilly and Company
Merck & Co.
Hoffmann-La Roche AG
Johnson & Johnson
Novartis International AG
AbbVie, Inc.
Pfizer Inc.
Sanofi S.A.
EMD Serono, Inc.
Gilead Sciences Inc.
Prometheus Therapeutics & Diagnostics
Aduro BioTech
Galena Biopharma
Bavarian Nordic
Celldex Therapeutics
ImmunoCellular Therapeutics
Incyte
Market Segment by Product Type
Immune Checkpoint Inhibitors
Monoclonal Antibodies
Cytokine-Based Immunotherapy
Cancer Vaccines
CAR-T Cell Therapy
Market Segment by Application
Hospitals
Pharmacies
Online Pharmacies
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Immuno-oncology Drugs status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Immuno-oncology Drugs manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Immuno-oncology Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Immuno-oncology Drugs Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Immune Checkpoint Inhibitors
- 1.3.3 Monoclonal Antibodies
- 1.3.4 Cytokine-Based Immunotherapy
- 1.3.5 Cancer Vaccines
- 1.3.6 CAR-T Cell Therapy
- 1.4 Market Segment by Application
- 1.4.1 Global Immuno-oncology Drugs Market Share by Application (2019-2025)
- 1.4.2 Hospitals
- 1.4.3 Pharmacies
- 1.4.4 Online Pharmacies
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Immuno-oncology Drugs Market Size
- 2.1.1 Global Immuno-oncology Drugs Revenue 2014-2025
- 2.1.2 Global Immuno-oncology Drugs Sales 2014-2025
- 2.2 Immuno-oncology Drugs Growth Rate by Regions
- 2.2.1 Global Immuno-oncology Drugs Sales by Regions 2014-2019
- 2.2.2 Global Immuno-oncology Drugs Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Immuno-oncology Drugs Sales by Manufacturers
- 3.1.1 Immuno-oncology Drugs Sales by Manufacturers 2014-2019
- 3.1.2 Immuno-oncology Drugs Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Immuno-oncology Drugs Revenue by Manufacturers (2014-2019)
- 3.2.2 Immuno-oncology Drugs Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Immuno-oncology Drugs Market Concentration Ratio (CR5 and HHI)
- 3.3 Immuno-oncology Drugs Price by Manufacturers
- 3.4 Key Manufacturers Immuno-oncology Drugs Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Immuno-oncology Drugs Market
- 3.6 Key Manufacturers Immuno-oncology Drugs Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Immune Checkpoint Inhibitors Sales and Revenue (2014-2019)
- 4.1.2 Monoclonal Antibodies Sales and Revenue (2014-2019)
- 4.1.3 Cytokine-Based Immunotherapy Sales and Revenue (2014-2019)
- 4.1.4 Cancer Vaccines Sales and Revenue (2014-2019)
- 4.1.5 CAR-T Cell Therapy Sales and Revenue (2014-2019)
- 4.2 Global Immuno-oncology Drugs Sales Market Share by Type
- 4.3 Global Immuno-oncology Drugs Revenue Market Share by Type
- 4.4 Immuno-oncology Drugs Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Immuno-oncology Drugs Sales by Application
6 United States
- 6.1 United States Immuno-oncology Drugs Breakdown Data by Company
- 6.2 United States Immuno-oncology Drugs Breakdown Data by Type
- 6.3 United States Immuno-oncology Drugs Breakdown Data by Application
7 European Union
- 7.1 European Union Immuno-oncology Drugs Breakdown Data by Company
- 7.2 European Union Immuno-oncology Drugs Breakdown Data by Type
- 7.3 European Union Immuno-oncology Drugs Breakdown Data by Application
8 China
- 8.1 China Immuno-oncology Drugs Breakdown Data by Company
- 8.2 China Immuno-oncology Drugs Breakdown Data by Type
- 8.3 China Immuno-oncology Drugs Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Immuno-oncology Drugs Breakdown Data by Company
- 9.2 Rest of World Immuno-oncology Drugs Breakdown Data by Type
- 9.3 Rest of World Immuno-oncology Drugs Breakdown Data by Application
- 9.4 Rest of World Immuno-oncology Drugs Breakdown Data by Countries
- 9.4.1 Rest of World Immuno-oncology Drugs Sales by Countries
- 9.4.2 Rest of World Immuno-oncology Drugs Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Amgen, Inc
- 10.1.1 Amgen, Inc Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Immuno-oncology Drugs
- 10.1.4 Immuno-oncology Drugs Product Introduction
- 10.1.5 Amgen, Inc Recent Development
- 10.2 AstraZeneca, Plc
- 10.2.1 AstraZeneca, Plc Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Immuno-oncology Drugs
- 10.2.4 Immuno-oncology Drugs Product Introduction
- 10.2.5 AstraZeneca, Plc Recent Development
- 10.3 Bristol-Myers Squibb
- 10.3.1 Bristol-Myers Squibb Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Immuno-oncology Drugs
- 10.3.4 Immuno-oncology Drugs Product Introduction
- 10.3.5 Bristol-Myers Squibb Recent Development
- 10.4 Celgene Corporation
- 10.4.1 Celgene Corporation Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Immuno-oncology Drugs
- 10.4.4 Immuno-oncology Drugs Product Introduction
- 10.4.5 Celgene Corporation Recent Development
- 10.5 Eli Lilly and Company
- 10.5.1 Eli Lilly and Company Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Immuno-oncology Drugs
- 10.5.4 Immuno-oncology Drugs Product Introduction
- 10.5.5 Eli Lilly and Company Recent Development
- 10.6 Merck & Co.
- 10.6.1 Merck & Co. Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Immuno-oncology Drugs
- 10.6.4 Immuno-oncology Drugs Product Introduction
- 10.6.5 Merck & Co. Recent Development
- 10.7 Hoffmann-La Roche AG
- 10.7.1 Hoffmann-La Roche AG Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Immuno-oncology Drugs
- 10.7.4 Immuno-oncology Drugs Product Introduction
- 10.7.5 Hoffmann-La Roche AG Recent Development
- 10.8 Johnson & Johnson
- 10.8.1 Johnson & Johnson Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Immuno-oncology Drugs
- 10.8.4 Immuno-oncology Drugs Product Introduction
- 10.8.5 Johnson & Johnson Recent Development
- 10.9 Novartis International AG
- 10.9.1 Novartis International AG Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Immuno-oncology Drugs
- 10.9.4 Immuno-oncology Drugs Product Introduction
- 10.9.5 Novartis International AG Recent Development
- 10.10 AbbVie, Inc.
- 10.10.1 AbbVie, Inc. Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of Immuno-oncology Drugs
- 10.10.4 Immuno-oncology Drugs Product Introduction
- 10.10.5 AbbVie, Inc. Recent Development
- 10.11 Pfizer Inc.
- 10.12 Sanofi S.A.
- 10.13 EMD Serono, Inc.
- 10.14 Gilead Sciences Inc.
- 10.15 Prometheus Therapeutics & Diagnostics
- 10.16 Aduro BioTech
- 10.17 Galena Biopharma
- 10.18 Bavarian Nordic
- 10.19 Celldex Therapeutics
- 10.20 ImmunoCellular Therapeutics
- 10.21 Incyte
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Immuno-oncology Drugs Sales Channels
- 11.2.2 Immuno-oncology Drugs Distributors
- 11.3 Immuno-oncology Drugs Customers
12 Market Forecast
- 12.1 Global Immuno-oncology Drugs Sales and Revenue Forecast 2019-2025
- 12.2 Global Immuno-oncology Drugs Sales Forecast by Type
- 12.3 Global Immuno-oncology Drugs Sales Forecast by Application
- 12.4 Immuno-oncology Drugs Forecast by Regions
- 12.4.1 Global Immuno-oncology Drugs Sales Forecast by Regions 2019-2025
- 12.4.2 Global Immuno-oncology Drugs Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Immuno-oncology Drugs. Industry analysis & Market Report on Immuno-oncology Drugs is a syndicated market report, published as Global (United States, European Union and China) Immuno-oncology Drugs Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Immuno-oncology Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
